Lund et al. (40) suggested that gut-derived glucagon might play a previously unknown role in secondary diabetes, following pancreatectomy, and possibly, although speculatively, also in the pathophysiology of other conditions following dietary hyperglucagonemia, including type 2 diabetes. The gene discussed is GCG; the disease is diabetes mellitus.